Quadrant Capital Group LLC Purchases 3,395 Shares of Agilent Technologies, Inc. $A

Quadrant Capital Group LLC raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 40.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,846 shares of the medical research company’s stock after buying an additional 3,395 shares during the quarter. Quadrant Capital Group LLC’s holdings in Agilent Technologies were worth $1,398,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of A. Verdence Capital Advisors LLC raised its stake in shares of Agilent Technologies by 5.0% during the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock worth $215,000 after acquiring an additional 86 shares in the last quarter. CENTRAL TRUST Co boosted its stake in Agilent Technologies by 3.7% in the second quarter. CENTRAL TRUST Co now owns 2,522 shares of the medical research company’s stock valued at $298,000 after acquiring an additional 89 shares in the last quarter. Burney Co. grew its holdings in Agilent Technologies by 4.8% in the second quarter. Burney Co. now owns 1,957 shares of the medical research company’s stock worth $231,000 after purchasing an additional 90 shares during the last quarter. Cary Street Partners Financial LLC increased its position in shares of Agilent Technologies by 2.9% during the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company’s stock worth $431,000 after purchasing an additional 103 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its holdings in shares of Agilent Technologies by 1.7% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,443 shares of the medical research company’s stock valued at $760,000 after purchasing an additional 110 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on A. Bank of America raised their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 25th. Rothschild & Co Redburn initiated coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target for the company. UBS Group boosted their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Finally, TD Cowen lifted their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $161.08.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the transaction, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.26% of the stock is owned by corporate insiders.

Agilent Technologies Trading Down 0.6%

Shares of NYSE:A opened at $153.48 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a market cap of $43.51 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 4.67 and a beta of 1.29. The business has a 50-day moving average price of $142.44 and a 200-day moving average price of $126.77.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the prior year, the company earned $1.46 EPS. Agilent Technologies’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Investors of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s dividend payout ratio is 22.32%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.